Generic Uloric

There are currently no generic Uloric (febuxostat) products available, as this medication is protected by a patent. Once this patent expires in March 2014, there may be several companies that manufacture a generic version of Uloric. However, lawsuits or other patents for specific uses of Uloric may extend or shorten the exclusivity period of this medication. Febuxostat is the "generic name" of Uloric; it is not a "generic version" of the drug.

Is a Generic Version of Uloric Available?

Uloric® (febuxostat) is a prescription medication approved for the treatment of gout. It belongs to a group of medications known as xanthine oxidase inhibitors.
 
Uloric is made by Takeda Pharmaceuticals America, Inc. Currently, Uloric is protected by patents that prevent any generic versions from being sold in the United States.
 

When Will Generic Uloric Be Available?

The first patent for Uloric currently expires in March 2014. This is the earliest predictable date that a generic version of Uloric could become available. However, there are other circumstances that could come up to extend or shorten the exclusivity period of Uloric. This could include such things as lawsuits or other patents for specific Uloric uses. Once Uloric goes off patent, there may be several companies that manufacture a generic Uloric drug.
 

Is Febuxostat a Generic Uloric?

No -- febuxostat hydrochloride is the active ingredient in Uloric, but it is not a generic version of Uloric. What can be confusing is that, oftentimes, the active ingredient of a drug is referred to as the "generic name." The generic name is different from a generic version of a medicine. In order for there to be a generic version of a medicine, the original medicine must have gone off patent, and another company besides the original manufacturer would make the product.
 
Written by/reviewed by: Kristi Monson, PharmD; Arthur Schoenstadt, MD
Last reviewed by: Kristi Monson, PharmD;
Other Articles in This eMedTV Presentation